Short answer
Neuronetics, Inc. (STIM) filed an 8-K current report with the SEC on April 6, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.05 (Costs Associated with Exit or Disposal Activities), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Former CEO Keith J. Sullivan retired under an agreement effective April 1, 2026.
Neuronetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Former CEO Keith J. Sullivan retired under an agreement effective April 1, 2026
- Consulting support continues through March 31, 2027 without additional cash compensation
- Outstanding equity awards continue vesting during the consultancy, extending retention-related compensation
- Release of employment claims and confidentiality, non-solicitation, and non-competition covenants reduce potential legal and competitive risk
Item 2.05 · Costs Associated with Exit or Disposal Activities
- Workforce reduction affecting up to 5% of employees, completion targeted by mid-year 2026
- Approximately $0.2 million restructuring charges expected in Q2 2026, primarily severance
- Annualized cost savings estimated at $2.5 million–$3.0 million
- Net savings expected to begin primarily in Q3 2026, supporting cost-structure optimization
Item 5.02 · Departure/Election of Directors or Officers
- CFO and Treasurer Steven E. Pfanstiel resigning effective May 1, 2026
- Successor search underway, creating near-term finance leadership transition risk
- Departure unrelated to disputes with management, the Board, or company practices
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure reiterates fiscal 2026 outlook covering revenue, expenses, growth, and upcoming quarters
- Greenbrook TMS transaction creates potential business-relationship and integration risks
- Profitability remains uncertain given history of losses, cash-balance constraints, and need to maintain positive cash flow
- Key execution risks include NeuroStar demand, reimbursement, salesforce scale, competition, regulation, and Better Me rollout timing
Item EX-99.1 · Exhibit EX-99.1
- CFO Steven E. Pfanstiel departing May 1, 2026 for external opportunity
- Resignation not related to disputes with management, Board, operations, policies, or practices
- Replacement search underway, creating near-term finance leadership transition risk
- Fiscal 2026 financial guidance reaffirmed, limiting immediate outlook concerns
- Filing flags retention, cash flow, credit facility, reimbursement, and Greenbrook transaction risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Neuronetics, Inc. 8-K filings
Get the next STIM 8-K as it lands
Follow STIM for push alerts, or ask the research agent what this filing means.